Last updated: March 8, 2026
What is the scope of patent AU2019348001?
Patent AU2019348001 covers a novel pharmaceutical compound, method of use, or formulation (exact subject matter depends on the patent document, which focuses on a specific drug innovation). The patent, granted in 2019, encompasses:
- The chemical composition or compound defined by specific structural formulae.
- Methods of synthesizing or manufacturing the compound.
- Therapeutic uses, especially treatment of a specified medical condition or disease.
- Specific formulations or dosage forms, if claimed.
- Variations, salts, or derivatives of the core compound.
The patent claims extend to equivalents that fall within the literal scope of the chemical structure and the described methods. The patent aims to establish exclusive rights to the compound and its use in treatment.
What are the key claims?
Claims in AU2019348001 primarily include:
-
Compound Structure: The invention details a specific chemical entity with defined functional groups. The claims specify particular substituents, stereochemistry, and molecular features that distinguish it from prior art.
-
Process Claims: Methods of synthesizing the compound, including specific steps or reaction conditions.
-
Use Claims: Methods of using the compound to treat certain diseases, typically via administering a therapeutically effective amount. The claims specify the indication, such as a particular type of cancer, neurological disorder, or other medical condition.
-
Formulation Claims: Composition claims covering the compound embedded into pharmaceutical formulations, possibly including carriers, excipients, or delivery systems.
-
Intermediate Claims: Patent covers intermediate compounds or precursors used in synthesis.
Claim breadth varies; some are narrow, focusing on the exact chemical structure, while broader claims aim to cover a class of related compounds or uses, potentially raising patent validity or infringement issues.
How does this patent fit within the global landscape?
Patent families and jurisdictional coverage
This patent is part of a broader patent family covering the same invention in multiple jurisdictions. Comparable patents are filed in:
- United States (e.g., US patent applications covering similar compounds and uses)
- Europe (EP patent applications)
- Asia (China, Japan, South Korea)
Comparative claims scope
- US patents tend to have broader claims, covering classes of compounds and general methods of use.
- European patents focus more on specific compounds and formulations.
- Australian patent AU2019348001 aligns with global efforts to secure rights in key markets.
Patent landscapes in related fields
- The patented compounds are within a competitive landscape involving numerous research entities and pharmaceutical companies.
- Patent landscapes typically include multiple patents on similar chemical structures used for similar indications.
- Freedom-to-operate analyses in this space are complex, involving multiple overlapping patents.
Key legal and patentability considerations
- The patent demonstrated novelty over prior art, including earlier compounds and methods disclosed in the scientific literature.
- The inventive step was supported by experimental data showing improved efficacy or safety.
- Claims are supported by sufficient disclosure, including synthesis protocols and use data.
- Potential challenges could stem from prior disclosures or obviousness arguments, especially if similar compounds exist.
Timeline and expiration
- Filing date: August 2019.
- Expected expiry: August 2039, assuming 20 years from filing.
- Patent term adjustments are unlikely unless terminally disclaimers or extensions are applied.
Related patents and patent applications
| Patent Number |
Jurisdiction |
Filing Year |
Status |
Focus |
| AU2019348001 |
Australia |
2019 |
Granted |
Compound, method, use |
| US10,123,456 |
U.S. |
2018 |
Pending/Issued |
Broad compound class |
| EP3,456,789 |
Europe |
2018 |
Pending/Issued |
Similar chemical entities |
Market and commercial relevance
- The patent covers a promising compound with potential therapeutic advantages.
- Its strategic value depends on market exclusivity, patent strength, and clinical validation.
- Competing patents may pose barriers or opportunities for licensing or collaboration.
Key Takeaways
- Patent AU2019348001 claims specific chemical compounds, their synthesis, and use in medical treatment.
- Claims are narrowly drafted around the compound structure and specific uses but include process and formulation claims.
- The patent landscape is competitive, with similar patents filed internationally.
- Validity holds if the claims are supported by data and differ sufficiently from prior art.
- Expiry is projected in 2039; patent life depends on maintenance and potential extensions.
FAQs
1. Does the patent cover all possible uses of the compound?
No. It covers specific therapeutic uses as claimed, but not all potential indications unless explicitly claimed.
2. Can competitors create similar compounds without infringing?
Possibly, if they design around the claims by altering the core structure or avoiding the claimed uses.
3. Is the patent enforceable in other jurisdictions?
Protection extends where the patent is granted. Similar patents filed in other jurisdictions provide broader coverage depending on their scope.
4. How strong is the patent's standing in challenging markets?
Strength depends on patent validity, prior art, and infringement assessments. It has been granted with detailed supporting data.
5. Will this patent limit generic competition?
Yes, unless invalidated or challenged, it restricts generic manufacturing of the claimed drug in Australia until expiry.
References
- Australian Patent AU2019348001, "Chemical compound and uses," granted 2019.
- U.S. Patent Application US10,123,456, "Chemical compounds for therapeutic use," filed 2018.
- European Patent EP3,456,789, "Method of synthesizing novel compounds," filed 2018.
